Treatment of refractory status epilepticus in childhood

Current Neurology and Neuroscience Reports

Volumn 11, Issue 2, 2011, Pages 195-204

  Schreiber, John M ^a   Gaillard, William D ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Corticosteroids; Desflurane; Electroconvulsive therapy; Hypothermia; Isoflurane; Ketamine; Ketogenic diet; Lacosamide; Levetiracetam; Lidocaine; Magnesium; Midazolam; Paraldehyde; Pediatric; Pentobarbital; Phenobarbital; Pregabalin; Propofol; Refractory status epilepticus; Resective surgery; Thiopental; Topiramate; Treatment; Valproic acid

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; DESFLURANE; DIAZEPAM; ETIRACETAM; FOSPHENYTOIN SODIUM; HARKOSERIDE; ISOFLURANE; KETAMINE; LORAZEPAM; MAGNESIUM; MIDAZOLAM; PARALDEHYDE; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PROPOFOL; THIOPENTAL; TOPIRAMATE; VALPROIC ACID; VERAPAMIL;

BENIGN CHILDHOOD EPILEPSY; BOLUS INJECTION; BRADYCARDIA; BRAIN ATROPHY; CARDIOPULMONARY INSUFFICIENCY; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; EXCHANGE BLOOD TRANSFUSION; EXTRACORPOREAL OXYGENATION; HEART ARREST; HEART RIGHT BUNDLE BRANCH BLOCK; HEMISPHERECTOMY; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOTENSION; HYPOTHERMIA; ILEUS; INDUCED HYPOTHERMIA; INFUSION RATE; INTESTINE ISCHEMIA; KETOGENIC DIET; LIVER TOXICITY; LOADING DRUG DOSE; LOW DRUG DOSE; METABOLIC ACIDOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS DISEASE; PATIENT MONITORING; PATIENT SELECTION; PROPOFOL INFUSION SYNDROME; QT PROLONGATION; REFRACTORY EPILEPTIC STATE; RESPIRATION DEPRESSION; REVIEW; RHABDOMYOLYSIS; SIDE EFFECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THROMBOCYTOPENIA; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VAGUS NERVE STIMULATION; VENTILATOR ASSOCIATED PNEUMONIA;

ANTICONVULSANTS; CHILD; ELECTROCONVULSIVE THERAPY; HUMANS; STATUS EPILEPTICUS; TREATMENT OUTCOME;

EID: 79955794256     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-010-0170-y     Document Type: Review

References (70)

1. Chin RF, Neville BG, Peckham C, et al.: Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: Prospective population-based study. Lancet 2006, 368: 222-229. (Pubitemid 44041084)
2. Lewena S, Pennington V, Acworth J, et al.: Emergency management of pediatric convulsive status epilepticus: a multicenter study of 542 patients. Pediatr Emerg Care 2009, 25: 83-87. This multicenter retrospective study identified 542 patients presenting to an emergency department with a convulsive seizure of at least 10 minutes duration. Convulsive SE was terminated after first-line therapy in 42%, second-line in 35% (or 60% of patients not responding to first-line agents), and rapid sequence induction of anesthesia in 22%. Seizure control was not achieved in two patients who died.
3. Dunn DW: Status epilepticus in children: Etiology, clinical features, and outcome. J Child Neurol 1988, 3: 167-173.
4. Singh RK, Stephens S, Berl MM, et al.: Prospective study of new-onset seizures presenting as status epilepticus in childhood. Neurology 2010, 74: 636-642.
5. Claassen J, Hirsch LJ, Emerson RG, et al.: Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology 2001, 57: 1036-1042. (Pubitemid 32880200)
6. Tasker RC, Boyd SG, Harden A, Matthew DJ: EEG monitoring of prolonged thiopentone administration for intractable seizures and status epilepticus in infants and young children. Neuropediatrics 1989, 20: 147-153. (Pubitemid 19209686)
7. Chen JW, Wasterlain CG: Status epilepticus: pathophysiology and management in adults. Lancet Neurol 2006, 5: 246-256. (Pubitemid 43238348)
8. Shinnar S, Hesdorffer DC: Pediatric status epilepticus: should the diagnostic evaluation change? Neurology 2010, 74: 624-625.
9. Gilbert DL, Gartside PS, Glauser TA: Efficacy and mortality of refractory generalized convulsive status epilepticus in children: a meta-analysis. J Child Neurol 1999, 14: 602-609. (Pubitemid 29431765)
10. Claassen J, Hirsch LJ, Emerson RG, Mayer SA: Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002, 43: 146-153. (Pubitemid 34225994)
11. Yaffe K, Lowenstein DH: Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus. Neurology 1993, 43: 895-900. (Pubitemid 23150558)
12. Novy J, Logroscino G, RossettiAO: Refractory status epilepticus: a prospective observational study. Epilepsia 2010, 51: 251-256. A total of 29 of 128 (22.6%) consecutive adult SE episodes were refractory, although only nine of these had generalized RSE. Twelve patients with RSE required coma induction and intubation to treat RSE (6/9 with generalized RSE).
13. Chin RF, Neville BG, Peckham C, et al.: Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study. Lancet Neurol 2008, 7:696-703. The authors prospectively collected information on 240 episodes of convulsive SE in 182 children and found that only 22% of episodes were terminated prehospital, whereas 18% required anesthesia for seizure termination. No treatment prehospital and two doses of benzodiazepines were associated with episodes that lasted for more than 60 minutes. IV lorazepam and IV phenytoin were more effective in terminating seizures compared with rectal diazepam and rectal paraldehyde, respectively.
14. Aranda A, Foucart G, Ducassé JL, et al.: Generalized convulsive status epilepticus management in adults: A cohort study with evaluation of professional practice. Epilepsia 2010, 51: 2159-2167.
15. Shinnar S, Berg AT, Moshe SL, Shinnar R: How long do new-onset seizures in children last? Ann Neurol 2001, 49: 659-664.
16. Sahin M, Menache CC, Holmes GL, Riviello JJ, Jr.: Outcome of severe refractory status epilepticus in children. Epilepsia 2001, 42: 1461-1467.
17. Delorenzo RJ, Waterhouse EJ, Towne AR, et al.: Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 1998, 39: 833-840. (Pubitemid 128721651)
18. Hosain SA, Solomon GE, Kobylarz EJ: Electroencephalographic patterns in unresponsive pediatric patients. Pediatric Neurology 2005, 32: 162-165. (Pubitemid 40269696)
19. Jette N, Claassen J, Emerson RG, Hirsch LJ: Frequency and predictors of nonconvulsive seizures during continuous electroencephalographic monitoring in critically ill children. Arch Neurol 2006, 63: 1750-1755. (Pubitemid 44925084)
20. Shahwan A, Bailey C, Shekerdemian L, Harvey AS: The prevalence of seizures in comatose children in the pediatric intensive care unit: A prospective video-EEG study. Epilepsia 2010, 51: 1198-1204. This is the first prospective study using continuous video-EEG monitoring for comatose pediatric patients in the ICU. Only 7 of 100 were found to have electrographic seizures; six had a history of epilepsy with epileptic seizures prior to ICU admission and one had a cardiac arrest.
21. Claassen J, Mayer SA, Kowalski RG, et al.: Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology 2004, 62: 1743-1748. (Pubitemid 38661728)
22. Eriksson K, Metsarant P, Huhtala H, et al.: Treatment delay and the risk of prolonged status epilepticus. Neurology 2005, 65: 1316-1318. (Pubitemid 41508236)
23. Treiman DM, Meyers PD, Walton NY, et al.: A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998, 339: 792-798. (Pubitemid 28447452)
24. Crawford TO, Mitchell WG, Fishman LS, Snodgrass SR: Very-high-dose phenobarbital for refractory status epilepticus in children. Neurology 1988, 38: 1035-1040.
25. Lee WK, Liu KT, Young BW: Very-high-dose phenobarbital for childhood refractory status epilepticus. Pediatr Neurol 2006, 34: 63-65. (Pubitemid 41821014)
26. Uberall MA, Trollmann R, Sunsiedler U, Wenzel D: Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus. Neurology 2000, 54: 2188-2189. (Pubitemid 30397234)
27. Mehta V, Singhi P, Singhi S: Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial. J Child Neurol 2007, 22: 1191-1197.
28. Cilio MR, Bianchi R, Balestri M, et al.: Intravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancy. Epilepsy Res 2009, 86: 66-71.
29. Abend NS, Florance N, Finkel RS, et al.: Intravenous levetiracetam terminates refractory focal status epilepticus. Neurocrit Care 2009, 10: 83-86.
30. Möddel G, Bunten S, Dobis C, et al.: Intravenous levetiracetam: a new treatment alternative for refractory status epilepticus. J Neurol Neurosurg Psychiatry 2009, 80: 689-692. Thirty-six adult patients were given levetiracetam for SE that failed at least one other AED. Factors associated with no response were lack of bolus dosing, daily dose over 3000 mg, and treatment latency over 48 hours. All seven patients with complex partial SE and all eight patients without brain lesions were responders.
31. Gallentine WB, Hunnicutt AS, Husain AM: Levetiracetam in children with refractory status epilepticus. Epilepsy Behav 2009, 14: 215-218.
32. Rossetti AO, Bromfield EB: Determinants of success in the use of oral levetiracetam in status epilepticus. Epilepsy Behav 2006, 8: 651-654.
33. Kellinghaus C, Berning S, Besselmann M: Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy. Epilepsy Behav 2009, 14: 429-431.
34. Tilz C, Resch R, Hofer T, Eggers C: Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide. Epilepsia 2010, 51: 316-317.
35. Kellinghaus C, Berning S, Immisch I, et al.: Intravenous lacosamide for treatment of status epilepticus. Acta Neurol Scand 2010 (Epub).
36. Parviainen I, Uusaro A, Kälviäinen R, et al.: High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit. Neurology 2002, 59: 1249-1251. (Pubitemid 35192399)
37. Koul RL, Aithala GR, Chacko A, et al.: Continuous midazolam infusion as treatment of status epilepticus. Arch Dis Child 1997, 76: 445-448. (Pubitemid 27261863)
38. Van Gestel JP, Blussé van Oud-Alblas HJ, Malingré M, et al.: Propofol and thiopental for refractory status epilepticus in children. Neurology 2005, 65: 591-592. (Pubitemid 41170720)
39. Rossetti AO, Milligan TA, Vulliémoz S, et al.: A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care 2010, (Epub).
40. Rossetti AO, Logroscino G, Bromfield EB: Refractory status epilepticus: Effect of treatment aggressiveness on prognosis. Arch Neurol 2005, 62: 1698-1702. (Pubitemid 41626665)
41. Stecker MM, Kramer TH, Raps EC, et al.: Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia 1998, 39: 18-26. (Pubitemid 28116837)
42. Goodkin HP, Joshi S, Mtchedlishvili Z, et al.: Subunit-specific trafficking of GABA-A receptors during status epilepticus. J Neurosci 2008, 28: 2527-2538. This study demonstrates that in hippocampal slices obtained from animals undergoing prolonged se there is decreased surface expression of the benzodiazepine-sensitive γ-subunit-containing GABA-A receptor, independent of ligand binding.
43. Rivera R, Segnini M, Aristides B, et al.: Midazolam in the treatment of status epilepticus in children. Crit Care Med 1993, 21: 991-994. (Pubitemid 23206189)
44. Holmes GL, Riviello JJ, Jr.: Midazolam and pentobarbital for refractory status epilepticus. Pediatr Neurol 1999, 20: 259-264.
45. Lampin ME, Dorkenoo A, Lamblin MD, et al.: Use of midazolam for refractory status epilepticus in children. Rev Neurol 2010, 166: 648-52.
46. Martella G, De Persis C, Bonsi P, et al.: Inhibition of persistent sodium current fraction and voltage-gated L-type calcium current by propofol in cortical neurons: implications for its antiepileptic activity. Epilepsia 2005, 46: 624-635. (Pubitemid 40628656)
47. Rossetti AO, Reichhart MD, Schaller MD, et al.: Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia 2004, 45: 757-763. (Pubitemid 38890973)
48. Parviainen I, Uusaro A, Kälviäinen R, et al.: Propofol in the treatment of refractory status epilepticus. Intensive Care Med 2006, 32: 1075-1079. (Pubitemid 43952725)
49. Iyer VN, Hoel R, Rabinstein AA: Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience. Crit Care Med 2009, 37: 3024-3030. Of 31 patients receiving propofol for RSE, 11 had non-life-threatening signs of PRIS and three had cardiac arrests. The 10 patients not receiving propofol did not exhibit any such signs. The occurrence of PRIS was associated with cumulative dose, peak dose, and duration.
50. Baumesiter FA, Oberhoffer R, Liebhaber GM, et al.: Fatal propofol infusion syndrome in association with ketogenic diet. Neuropediatrics 2004, 35: 250-252. (Pubitemid 39215606)
51. Da-Silva SS, Wong R, Coquillon P, et al.: Partial-exchange blood transfusion: an effective method for preventing mortality in a child with propofol infusion syndrome. Pediatrics 2010, 125: e1493-e1499.
52. Guitton C, Gabillet L, Latour P, et al.: Propofol infusion syndrome during refractory status epilepticus in a young adult: successful ECMO resuscitation. Neurocrit Care 2010 (Epub).
53. Wheless JW: Treatment of refractory convulsive status epilepticus in children: other therapies. Semin Pediatr Neurol 2010, 17: 190-194.
54. Hamano S, Sugiyama N, Yamashita S, et al.: Intravenous lidocaine for status epilepticus during childhood. Dev Med Child Neurol 2006, 48: 220-222. (Pubitemid 44404269)
55. Kahriman M, Minecan D, Kutluay E, et al.: Efficacy of topiramate in children with refractory status epilepticus. Epilepsia 2003, 44: 1353-1356. (Pubitemid 37280381)
56. Blumkin L, Lerman-Sagie T, Houri T, et al.: Pediatric refractory partial status epilepticus responsive to topiramate. J Child Neurol 2005, 20: 239-241. (Pubitemid 40561772)
57. Perry MS, Holt PJ, Sladky JT: Topiramate loading for refractory status epilepticus in children. Epilepsia 2006, 47: 1070-1071. (Pubitemid 43801519)
58. Novy J, Rossetti AO: Oral pregabalin as an add-on treatment for status epilepticus. Epilepsia 2010, 51: 2207-2216. Pregabalin was started for 11 of 230 patients with SE, mostly partial RSE. Pregabalin and other oral antiepileptics may effectively treat partial RSE without the need for ICU admission or intubation.
59. Mewasingh LD, Sekhara T, Aeby A, et al.: Oral ketamine in paediatric non-convulsive status epilepticus. Seizure 2003, 12: 483-489. (Pubitemid 37168637)
60. Prüss H, Holtkamp M: Ketamine successfully terminates malignant status epilepticus. Epilepsy Res 2008, 82: 219-222.
61. Ubogu EE, Sagar SM, Lerner AJ, et al.: Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity. Epilepsy Behav 2003, 4: 70-75. (Pubitemid 36546455)
62. Visser NA, Braun KP, Leijten FS, et al.: Magnesium treatment for patients with refractory status epilepticus due to POLG1 mutations. J Neurol 2010, (Epub).
63. Schmitt FC, Dehnicke C, Merschhemke M, Meencke HJ: Verapamil attenuates the malignant treatment course in recurrent status epilepticus. Epilepsy Behav 2010, 17: 565-568. This study invokes a novel principle in RSE treatment, taking advantage of verapamil's properties as a potent multidrug transport inhibitor to reduce pharmacoresistance to other AEDs.
64. Kumada T, Miyajima T, Kimura N, et al.: Modified Atkins diet for the treatment of nonconvulsive status epilepticus in children. J Child Neurol 2010, 25: 485-489.
65. Nabbout R, Mazzuca M, Humbert P, et al.: Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 2010, 51: 2033-2037. In 7 of 9 patients with FIRES, KD was efficacious within 2 to 4 days (mean, 2 days) following the onset of ketonuria and 4 to 6 days (mean, 4.8 days) following the onset of the diet. This is a new application for the KD in a condition that is difficult to treat.
66. Orlowski JP, Erenber G, Lueders H, et al.: Hypothermia and barbiturate coma for refractory status epilepticus. Crit Care Med 1984, 12: 367-372. (Pubitemid 14135830)
67. Corry JJ, Dhar R, Murphy T, Diringer MN: Hypothermia for refractory status epilepticus. Neurocrit Care 2008, 9: 189-197.
68. Kamel H, Cornes SB, Hegde M, et al.: Electroconvulsive therapy for refractory status epilepticus: a case series. Neurocrit Care 2010, 12: 204-210.
69. Vendrame M, Loddenkemper T: Surgical treatment of refractory status epilepticus in children: Candidate selection and outcome. Semin Pediatr Neurol 2010, 17: 182-189.
70. Schrader DV, Steinbok P, Connolly M: Urgent, resective surgery for medically refractory, convulsive status epilepticus. Eur J Paediatr Neurol 2009, 13: 10-17.